For Healthcare Professionals
Print   |   Adjust Font Size:  A  A  A    
IMMUNO-ONCOLOGY
A New Frontier in Cancer Research


Cancer is smart. We're seeking to make the immune system smarter.

The Approach

The immune system is a powerful and adaptable network of cells and pathways that protects the body from infection and may also be engaged to target and destroy cancer cells.1 The potential of the immune system’s intrinsic ability to fight cancer is fundamental to the Immuno-Oncology research and development programs at Bristol-Myers Squibb, and our ongoing commitment to fight cancer.1-3

Read more about the Immuno-Oncology Approach.

BMS Immuno-Oncology

BMS’s Immuno-Oncology portfolio and visionary science is focused on harnessing the intelligence of the immune system to fight cancer.1

Read more about BMS & I-O.

Keeping Up

Find out about the latest developments in I-O, including ongoing clinical trials.

Clinical trials


 

1. Borghaei H, Smith MR, Campbell KS. Immunotherapy of cancer. Eur J Pharmacol. 2009;625:41-54. 2. Finn OJ. Cancer immunology. N Engl J Med. 2008;358:2704-2715. 3. Lizee G, Cantu MA, Hwu P. Less yin, more yang: confronting the barriers to cancer immunotherapy. Clin Cancer Res. 2007;13:5250-5255.
© 2012 Bristol-Myers Squibb Company
Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.

You are about to leave BMSImmunoOncology.com

This Internet site may provide links or references to other sites. Bristol-Myers Squibb has no responsibility for the content of such other sites and is not liable for any damages or injury arising from that content. Any links to other sites are provided merely as a convenience to the users of this Internet site.

Click "Cancel" to return to BMSImmunoOncology.com or "OK" to proceed.

OK Cancel